NovoCure Ltd Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 60.30 | 11,175 | 673,853 | 65,037 | 76.2 K to 65 K (-14.66 %) |
| Jun 21 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | M | 11.85 | 12,500 | 148,125 | 25,000 | |
| Jun 21 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 60.00 | 12,500 | 750,000 | 76,212 | 88.7 K to 76.2 K (-14.09 %) |
| Jun 21 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Buy | M | 11.85 | 12,500 | 148,125 | 88,712 | 76.2 K to 88.7 K (+16.40 %) |
| Jun 21 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 25,000 | 86,000 | 29,743 | |
| Jun 21 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 60.02 | 25,000 | 1,500,500 | 69,504 | 94.5 K to 69.5 K (-26.45 %) |
| Jun 21 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 25,000 | 86,000 | 94,504 | 69.5 K to 94.5 K (+35.97 %) |
| Jun 21 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 11.46 | 25,000 | 286,500 | 25,000 | |
| Jun 21 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 61.46 | 25,000 | 1,536,500 | 258,311 | 283.3 K to 258.3 K (-8.82 %) |
| Jun 21 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 11.46 | 25,000 | 286,500 | 283,311 | 258.3 K to 283.3 K (+9.68 %) |
| Jun 21 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 22.00 | 110,868 | 2,439,096 | 36,957 | |
| Jun 21 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 60.00 | 110,868 | 6,652,080 | 185,674 | 296.5 K to 185.7 K (-37.39 %) |
| Jun 21 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 22.00 | 110,868 | 2,439,096 | 296,542 | 185.7 K to 296.5 K (+59.71 %) |
| Jun 19 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 14.37 | 190,338 | 2,735,157 | 0 | |
| Jun 19 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 59.37 | 190,338 | 11,300,367 | 258,311 | 448.6 K to 258.3 K (-42.42 %) |
| Jun 19 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 14.37 | 190,338 | 2,735,157 | 448,649 | 258.3 K to 448.6 K (+73.69 %) |
| Jun 13 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 14.37 | 30,436 | 437,365 | 190,338 | |
| Jun 13 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 14.37 | 16,835 | 241,919 | 220,774 | |
| Jun 13 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 55.74 | 18,203 | 1,014,544 | 258,311 | 276.5 K to 258.3 K (-6.58 %) |
| Jun 13 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 54.89 | 12,233 | 671,420 | 276,514 | 288.7 K to 276.5 K (-4.24 %) |
| Jun 13 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 14.37 | 30,436 | 437,365 | 288,747 | 258.3 K to 288.7 K (+11.78 %) |
| Jun 13 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 55.43 | 850 | 47,111 | 258,311 | 259.2 K to 258.3 K (-0.33 %) |
| Jun 13 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 54.71 | 15,985 | 874,539 | 259,161 | 275.1 K to 259.2 K (-5.81 %) |
| Jun 13 2019 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 14.37 | 16,835 | 241,919 | 275,146 | 258.3 K to 275.1 K (+6.52 %) |
| Jun 12 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 55.60 | 60 | 3,336 | 76,212 | 76.3 K to 76.2 K (-0.08 %) |
| Jun 12 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 55.02 | 1,070 | 58,876 | 76,272 | 77.3 K to 76.3 K (-1.38 %) |
| Jun 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 54,743 | |
| Jun 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 55.60 | 100 | 5,560 | 69,504 | 69.6 K to 69.5 K (-0.14 %) |
| Jun 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 55.04 | 4,900 | 269,706 | 69,604 | 74.5 K to 69.6 K (-6.58 %) |
| Jun 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 74,504 | 69.5 K to 74.5 K (+7.19 %) |
| Jun 10 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 7.15 | 5,999 | 42,893 | 103,014 | |
| Jun 10 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 54.79 | 5,999 | 328,661 | 185,674 | 191.7 K to 185.7 K (-3.13 %) |
| Jun 10 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 7.15 | 5,999 | 42,893 | 191,673 | 185.7 K to 191.7 K (+3.23 %) |
| Jun 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 7.15 | 17,500 | 125,125 | 109,013 | |
| Jun 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 54.14 | 17,500 | 947,485 | 185,674 | 203.2 K to 185.7 K (-8.61 %) |
| Jun 06 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 7.15 | 17,500 | 125,125 | 203,174 | 185.7 K to 203.2 K (+9.43 %) |